Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eoquin after TURBT in NMIBC
NCT01475266Phase 3Terminated
- Sponsor
- Nippon Kayaku Co., Ltd.
- Start
- Nov 2011
- Primary completion
- Apr 2013
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of apaziquone in Non-muscle-invasive bladder cancer (NMIBC), sponsored by Nippon Kayaku Co., Ltd.. Started Nov 2011; status: terminated.
02
Drugs
apaziquone
03
Conditions
Non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT01475266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01475266.